NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT07806149
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT07806149
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07806149. Non-randomized; no masking; primary purpose treatment. Start 2026-11-23 (anticipated); primary completion 2029-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
- Condition
- Hypertrophic Cardiomyopathy
- Condition
- Left Ventricular Outflow Obstruction
- Condition
- Systolic Anterior Motion
- Intervention (Device)
- SESAME Procedure
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct07806149- Content hash
d87ca6c815119aec84d4cf6b04fef94bf712e272d9ad24d78a1fe0dd51c79542